Time course of phthalate cumulative risks to male developmental health over a 27-year period: Biomonitoring samples of the German Environmental Specimen Bank by Apel, P et al.
Contents lists available at ScienceDirect
Environment International
journal homepage: www.elsevier.com/locate/envint
Time course of phthalate cumulative risks to male developmental health
over a 27-year period: Biomonitoring samples of the German Environmental
Specimen Bank
Petra Apela,⁎, Andreas Kortenkampb,⁎, Holger M. Kochc, Nina Vogela, Maria Rüthera,
Monika Kasper-Sonnenbergc, Andre Conrada, Thomas Brüningc, Marike Kolossa-Gehringa
aGerman Environment Agency (UBA), Corrensplatz 1, 14195 Berlin, Germany
b Brunel University London, Department of Life Sciences, College of Health and Life Sciences, Kingston Lane, Uxbridge, Middlesex UB8 3PH, United Kingdom
c Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1,
44789 Bochum, Germany
A R T I C L E I N F O








A B S T R A C T
In several human biomonitoring surveys, changes in the usage patterns of phthalates have come to light, but
their influence on the risks associated with combined exposures is insufficiently understood. Based on the largest
study to date, the 27-year survey of urinary phthalate metabolite levels in 24-hour urine samples from the
German Environmental Specimen Bank, we present a deep analysis of changing phthalate exposures on mixture
risks. This analysis adopts the Hazard Index (HI) approach based on the five phthalates DBP, DIBP, BBP, DEHP
and DINP. Calculations of the hazard index for each study participant included updated phthalate reference
doses for anti-androgenicity (RfDAAs) that take account of new evidence of phthalates’ developmental toxicity.
The Maximum Cumulative Ratio (MCR) approach was used to establish whether a subject’s combined ex-
posure was dominated by one phthalate or was influenced by several phthalates simultaneously. Generally, over
the years there was a shift towards lower HIs and higher MCRs, reflecting an increased complexity of the
combined exposures. The decade from 1988 to about 1999 was characterised by rather high HIs of between 3
and 7 (95th percentile) which were driven by exposure to DBP and DEHP, often exceeding their single acceptable
exposures. Traditional single phthalate risk assessments would have underestimated these risks by up to 50%.
From 2006 onwards, no study participant experienced exposures above acceptable levels for a single phthalate,
but combined exposures were still in excess of HI = 1. From 2011 onwards most individuals stayed below
HI = 1. In interpreting these results, we caution against the use of HI = 1 as an acceptable limit and develop
proposals for improved and more realistic mixture risk assessments that take account of co-exposures to other
anti-androgenic substances also capable of disrupting the male reproductive system. From this perspective, we
regard HIs between 0.1 and 0.2 as more appropriate for evaluating combined phthalate exposures. Assessed
against lowered HIs of 0.1 – 0.2, the combined phthalate exposures of most study participants exceeded ac-
ceptable levels in all study years, including 2015. Continued monitoring efforts for phthalate combinations are
required to provide the basis for appropriate risk management measures.
1. Introduction
Due to their uses as additives and plasticisers in a multitude of
consumer articles such as plastic bags, polyvinyl flooring, personal care
products, pharmaceuticals, medical devices, cleaning materials and
children’s toys, there is widespread human exposure to multiple
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phthalates. This has led to concerns about possible health impacts,
especially of combined exposures.
Phthalates and their metabolites can cross the placental barrier and
reach the foetus (Heudorf et al., 2007) where they act during a specific
time period in pregnancy when the programming of male sexual de-
velopment is established (late 1st to early 2nd trimester in humans).
This developmental step is driven by androgens and a host of other
factors. Certain phthalate metabolites can suppress InsL3 peptide hor-
mone production and testosterone synthesis in foetal Leydig cells (Gray
et al., 2000). Without InsL3, the gubernacular cord cannot develop
properly, leading to the disruption of testis descent. Suppression of
testosterone synthesis alters the entire developmental trajectory of the
male reproductive tract with long-lasting and often irreversible effects
on male reproductive health. These include increased risks of non-
descending testicles, hypospadias, poor semen quality and testis cancer
(for an authoritative review see Skakkebaek et al., 2016). From studies
in animals it is well known that phthalates with a backbone chain
length between three and six carbon atoms and a total carbon count of
the alkyl chain between 4 (DBP and DIBP) and 9 carbon atoms (DINP)
can suppress foetal testicular testosterone production. As a result, both,
structural and functional impairments of male reproduction and de-
velopment have been observed, termed the “phthalate syndrome”
(Foster, 2006; Gray et al., 2006; National Research Council, 2008;
Danish EPA, 2011; ECHA, 2009; 2014a; 2014b; Furr et al., 2014). These
anti-androgenic properties are considered to be of human health re-
levance (Albert and Jégou, 2014), and accordingly, DBP, DIBP, BBP,
DPP, and DEHP have been classified as reproductive toxicants in
Europe.
The importance of considering combined phthalate exposures is
underlined by experimental evidence showing that several phthalates
together produce adverse reproductive and developmental effects,
which are usually stronger than any single phthalate effect in the
mixture (reviewed by Kortenkamp, 2020; Howdeshell et al., 2017). In
the light of these findings, the US National Academy of Sciences called
for mixture risk assessments of phthalates and suggested the use of the
Hazard Index (HI) approach to achieve this goal (USNAS, 2008).
For all chemicals considered in a mixture risk assessment, the HI
sums risk quotients (RQ) of estimated daily intakes (DI) and reference
doses (RfD) for relevant health endpoints (Teuschler and Hertzberg,
1995). The utility of this approach for combined phthalate exposures
was first shown by Benson (2009) and then expanded by Kortenkamp
and Faust (2010) to include exposures to other substances capable of
producing reproductive and developmental toxicity by anti-androgenic
modes of action. Since then, several phthalate mixture risk assessments
have been published (Table 1). To varying degrees, these studies re-
vealed exceedances both of acceptable single and combined phthalate
exposures. Due to their high prevalence and high potency in disrupting
male sexual development, DBP and DEHP generally contributed most to
the HI.
However, the outcomes of these various phthalate mixture risk as-
sessments are difficult to compare. Not only were different phthalates
investigated and evaluated using different reference doses, there is also
evidence that phthalate exposures have undergone changes over the
years. Covering a period of 27 years, from 1988 to 2015, the survey of
changing phthalate exposures by Koch et al. (2017) is the largest of its
kind to date. Urinary phthalate metabolite levels in 24-hour urine
samples from the Environmental Specimen Bank (ESB) of the German
Federal Ministry for the Environment, Nature Conservation and Nuclear
Safety (BMU) (Kolossa-Gehring et al., 2012) were monitored. During
this period, exposures to DEP, DBP, DIBP, BBP, and DEHP declined,
while there was an increase in the levels of DINP metabolites. In a
survey of morning spot urine samples from first-time mothers in
Sweden decreases of DEP, DBP, BBP and DEHP metabolites were also
noticed between 2009 and 2014 (Gyllenhammer et al., 2017), while
DINP metabolite levels remained unchanged. Shu et al. (2018) saw
declines in DEP and DEHP in spot urine samples from the Swedish
SELMA cohort between 2007 and 2010. The levels of DINP increased,
while DBP and BBP metabolites showed fluctuations, with no clear
overall trend. Declining exposures to DEP, DBP, BBP and DEHP were
also found in an Italian study that compared the urinary metabolite
levels in 2011 and 2016 (Tranfo et al., 2018). Similar temporal trends
became apparent in analyses of spot urine samples from the NHANES
programme in the USA covering the time between 2001 and 2010 (Zota
et al., 2014) and 2004 to 2014 (Reyes and Price, 2018).
The implications of these trends for cumulative risks have not been
investigated. The declining exposures to most classical phthalates
shown by Koch et al. (2017), Gyllenhammar et al. (2017), Tranfo et al.
(2018), Shu et al. (2018), Zota et al. (2014) and Reyes and Price (2018)
can be expected to have a decreasing impact on combined risks, but
mixture risk assessments that consider the impact of changing exposure
patterns are comparatively rare. To our knowledge, Reyes and Price
(2018) is the only study of its kind. They observed generally declining
HIs during the period of 2005 to 2014 but also shifts in the contributing
phthalates.
Here, we present a comprehensive analysis of the impact of chan-
ging phthalate exposures on mixture risks in Germany by using the HI
approach, based on the study by Koch et al. (2017). This survey has
several advantages. Not only does it cover the longest time period
studied to date (27 years), it is also based on 24-hour urine samples.
The collection of 24-hour urine samples decreases uncertainties in ex-
posure assessments by eliminating the need to apply creatinine- or ur-
inary volume-based corrections to metabolite concentrations. This is of
importance as phthalates are rapidly metabolised, leading to con-
siderable variations in the metabolite levels found in individual sub-
jects, with diurnal and weekly changes. As they diminish the influence
of diurnal changes, 24-hour samples are also less likely to overestimate
inter-individual variations in phthalate metabolite concentrations. Spot
urine samples, most widely used in phthalate biomonitoring studies
(Table 1), are sensitive to such variations. Analyses of temporal trends
based on spot samples may therefore overlook some changes in ex-
posure patterns over time as these may be obscured (Lermen et al.,
2019).
Our interest was to establish whether a subject’s combined exposure
was dominated by one phthalate or was influenced by several phtha-
lates simultaneously. This will show the extent of cumulative risks that
is missed in traditional single chemical risk assessments. A convenient
way of addressing this issue is to calculate the ratio of an individual’s HI
(HIp) and the maximum RQ among the RQs that sum to the HI, called
Maximum Cumulative Ratio (MCR, here termed MCRp, see Materials
and Methods) (Price and Han 2011). By definition, the MCR cannot
exceed the number of mixture components, in our case five. The MCR
equals 5 when the RQs of all phthalates contribute equally to the HI.
The value of MCR approaches 1 where only one phthalate makes up
virtually 100% of the HI.
The ratio of the total impact of a combined exposure (equivalent to
the HI) to the largest single-chemical impact (equivalent to RQ max) was
originally used by Könemann (1981) to distinguish types of joint action
of chemicals in fish, and by Junghans et al. (2006) to establish the
factors that determine the degree of divergent predictions of mixture
effects derived from the assessment concepts of dose addition and in-
dependent action. Price et al. (2012) employed the MCR to group ex-
posure scenarios into categories that can support risk management
decisions. By creating scatter plots of MCRp versus HIp different
groupings can be distinguished (Fig. 1).
We used these groupings and the labelling introduced by Price et al.
(2012) to characterise how changing phthalate exposures evolved in
terms of: exceedances of acceptable combined and single exposures
(Region I in Fig. 1), exceedances of acceptable combined exposures
(Region III) and combined exposures where multiple phthalates con-
tribute to exceedances of the HI (Regions IIIb and Ib).
The quality of phthalate mixture risk assessments depends on the
quality of the reference doses utilised, but there are issues with the
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values employed in previous assessments. The TDIs for individual
phthalates derived by EFSA in 2005 and the reference doses for anti-
androgenic effects (RfDAA) proposed by Kortenkamp and Faust (2010)
were most widely used, often side-by-side (see HI, Table 1). Both sets of
values require updates and revisions because new evidence of anti-an-
drogenic effects of phthalates has emerged after 2010. Both, the EFSA
values and those by Kortenkamp and Faust (2010), are based on partly
outdated toxicity information and should no longer be used in phthalate
mixture risk assessments. Recently, Kortenkamp and Koch (2020) have
derived new RfDAAs for DBP, DIBP, BBP, DEHP and DINP (Table 2) and
we employ these new values for our analysis of temporal trends of
phthalate exposures in Germany.
As much as possible, the new RfDAAs are based on effect doses for
common endpoints of the phthalate syndrome, with the same effect
magnitude (benchmark doses). This ensures consistency and removes
some of the uncertainties inevitably introduced by the HI method
through the mixing of reference doses based on different toxicity end-
points, effect magnitudes, species and varying uncertainty factors. The
new values strike a balance between the need for consistency in terms
of these principles and the requirement of realising a reasonable degree
of protection. This was achieved by relying as much as possible on data
related to suppression of foetal testicular testosterone synthesis, an ef-
fect common for many phthalates, including DIBP, BBP and DINP. For
these three phthalates, other effects that make up the phthalate syn-
drome occurred at higher doses. However, in the case of DBP and
DEHP, reliance on testosterone suppression would have been in-
sufficiently protective, as effects that are also part of the phthalate
syndrome (reduced spermatocyte development for DBP and mild dys-
genesis of genitalia for DEHP), occur at lower doses than those neces-
sary for producing suppressions of foetal testosterone synthesis. The
data quality for these endpoints made it difficult to estimate benchmark
doses for DBP and DEHP. For this reason, it was necessary to derive
RfDAAs from lowest-observed-adverse-effect-levels in these cases
(Table 2). The details of derivation of the new RfDAAs are described in
Kortenkamp and Koch (2020).
Due to the need for accommodating the consistency required for






















Fig. 1. Example scatter plot of Maximum Cumulative Ratio (MCR) versus
Hazard Index (HI) with categories for risk management. Each study participant
in this example is depicted by a data point (the data shown here are fictitious
and have no further meaning). The blue segment to the left of the vertical line
marking an acceptable HI (here = 1) contains individuals who experienced
combined exposures that do not present concerns (Region II; we follow the
labelling introduced by Price et al., 2012). The white segment defined by the
vertical line for acceptable HIs and the curved line depicting MCR = HI shows
subjects with combined exposures above HI = 1, but without exceeding ac-
ceptable levels for any single phthalate (Region III). The red segment to the
right of the MCR = HI line is for subjects exceeding acceptable combined ex-
posures and with phthalate exposures above acceptable levels for at least one
phthalate (Region I). Data points below the horizontal line corresponding to
MCR = 2 show subjects in whom one phthalate contributed 50% or more to the
HI (Regions Ia, IIa and IIIa). Above this line are study participants who ex-
perienced combined exposures where multiple phthalates contributed to the HI
(Regions Ib, IIb and IIIb).
Table 2
Points-of-Departure (POD) and Reference Doses (RfD) for phthalate mixture risk assessments.




EFSA (2005a, 2005b, 2005c,
2005d) TDI (µg/kg/day)
Kortenkamp and Faust (2010)
RfDAA (µg/kg/day)
DBP 2 (LOAEL) 3 LOAEL - NOAEL 0.67 6.7 10 100
Endpoint Spermatocyte
development
Spermatocyte development T suppression
Species Rat Rat Rat
Reference Lee et al., 2004 Lee et al., 2004 NRC, 2008
DIBP 10 (BMDL) 1 10 100 no value 200
Endpoint T suppression T suppression
Species Rat Rat
Reference Hannas et al., 2011 NRC, 2008
BBP 1 (BMDL) 1 1 10 500 330
Endpoint T suppression AGD reduction T suppression
Species Rat Rat Rat
Reference Furr et al., 2014 Tyl et al., 2004 NRC, 2008
DEHP 3 (LOAEL) 3 LOAEL - NOAEL 1 10 50 30
Endpoint Dysgenesis of genitalia Testicular toxicity Nipple retention
Species Rat Rat Rat
Reference Christiansen et al.,
2010
Wolfe and Layton, 2003 Christiansen et al., 2009
DINP 5.9 (BMDL) 1 5.9 59 150 1500
Endpoint T suppression Hepatic effects T suppression
Species Rat Dog Rat
Reference Clewell et al., 2013 Gray et al., 2000
* with UF = 100 from adjusted POD
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for all phthalates included in our mixture risk assessment may not be
suitable for risk assessments with an orientation on single phthalates, as
these may show low dose effects relating to endpoints other than those
belonging to the phthalate syndrome.
2. Materials and methods
2.1. Provenance of urine samples
All 24-hour urine samples collected between 1988 and 2015 were
from students of the University of Münster (Germany). For each year,
samples from 30 males and 30 females were collected. In a few cases
one or two samples were excluded for further analysis in order to
maintain age consistency (age range 20–29 years). There were no sta-
tistically significant differences between males and females (Koch et al.,
2017). We therefore did not stratify the analysis according to gender,
and there was no need to exclusively focus on females, considering that
the risk assessment concerns vulnerable periods in foetal life and
women of reproductive age. Detailed information for all study years,
together with ethical approvals are given by Koch et al. (2017).
2.2. Quantification of phthalate metabolites
The quantification of phthalate metabolites was carried out by on-
line high-performance liquid chromatography and tandem mass spec-
trometry (HPLC-MS/MS) using internal isotope-labelled standards as
described by Koch et al. (2017). Metabolite concentrations below the
limit of quantification (LOQ) were set as LOQ/2. None of our analytical
findings were sensitive to this decision. For the phthalates DIBP and
DBP all samples had levels above the LOQ, for BBP 99.7% were above
LOQ. With DEHP, all three oxidised metabolites showed levels above
the LOQ, while the simple monoester MEHP was found above the LOQ
in 96.3% of the samples. For DINP, all three oxidised metabolites were
present at levels above the LOQ in 97.0 to 99.7% of the samples.
2.3. Estimation of daily intakes
For each study subject, we estimated daily intakes (DI) for DBP,
DIBP, BBP, DEHP and DINP based on the urinary metabolite levels
reported in Koch et al. (2017). We employed the reverse toxico-kinetic
model described by Koch et al. (2007). For DBP, DIBP and BBP the































DIp (µg/kg bw/day) is the daily intake of the unmetabolised parent
phthalate, ucm the urinary concentration of the metabolite (expressed as
µg/l),MWm the molecular weight of the metabolite (in g/mol),MWp the
molecular weight of the parent phthalate (in g/mol), uv the 24- hour
urine volume (l/day), Fue the molar urinary excretion factor for the
metabolite, and bw the body weight of the study subject (in kg).
For DEHP and DINP we estimated the daily intake by considering a





















































Here, the subscripts m1 and m2 refer to the respective metabolites. The
molar urinary excretion factors Fue of all metabolites were summed. All
parameters for calculation are given in Table 3.
2.4. Mixture risk assessment
For each study participant and year, we built risk quotients for DBP,
DIBP, BBP, DEHP and DINP by division of estimated daily intakes by























For each study subject and year, we then calculated the HIp by
summing the RQp derived for each single phthalate:
= + + + +HI RQ RQ RQ RQ RQp DBP DIBP BBP DEHP DINP
We further analysed the contribution of single phthalates to the sum
of RQ by calculating the Maximum Cumulative Ratio (MCR) for each
study subject. The MCRp is the ratio of the HIp and the RQp with the
highest numerical value among RQDBP, RQDIBP, RQBBP, RQDEHP and
RQDINP:
=MCR HI RQ max/p p p phthalate,
For every study year, the MCRp were then used to create scatter
plots of MCRp versus HIp which yielded data points representing each
study participant.
By creating these scatter plots of MCRp versus HIp several groupings
can be distinguished (Fig. 1) which we have labelled following Price
et al. (2012). While their labelling is not intuitive, we have adopted it
here to align our work with several publications on MCR by Price and
associates. Data points to the left of a vertical line demarcating an ac-
ceptable HI (commonly HI = 1, but values < 1 are possible, see
Discussion) depict individuals who experienced combined exposures
that do not present concerns (Region II). Conversely, data points to the
right of that line show subjects who exceeded their acceptable com-
bined exposures. These individuals fall into two separate categories:
Data points that sit in the segment defined by the vertical line for ac-
ceptable HIs and the curved line depicting MCR = HI signify in-
dividuals that have experienced unacceptable combined exposures
without exceeding acceptable levels for any single phthalate (Region
III). Conversely, data points to the right of the MCR = HI line show
study participants with phthalate exposures above acceptable levels for
at least one phthalate (Region I). In turn, each of these three categories
can be divided into two subgroups according to their MCR. Data points
below the horizontal line corresponding to MCR = 2 show individuals
where one phthalate contributed 50% or more to the HI (Regions Ia, IIa
and IIIa). Above this line are subjects who experienced combined ex-
posures where multiple phthalates contributed to the HI (Regions Ib, IIb
and IIIb).
With these groupings, Price et al. (2012) identified the following
risk management options: Regions I and III signal concerns as accep-
table combined exposures are exceeded. For Regions Ia and IIIa these
issues can be mitigated by targeting one phthalate with exposure re-
duction measures. The unacceptable exposures to several phthalates
experienced by Region Ib subjects can be addressed by reducing ex-
posures to several phthalates. In contrast, Region IIIb represents sub-
jects with unacceptable risks which would have gone unnoticed during
conventional single phthalate risk assessment and can only be ad-
dressed through cumulative risk assessment.
We also analysed the degree to which single phthalates drive cu-
mulative exposures by preparing plots of log (MCR – 1) versus log HI
(Reyes and Price 2018). Such plots are a convenient way of separating
exposures where one phthalate contributed at least 50% to the com-
bined exposures (MCR ≤ 2; log (MCR – 1) < 0) from those with more
complex patterns. Study participants with MCR > 2 and falling into
Regions Ib, IIb or IIIb are visualised by data points above the zero line
in these plots.




Table 4 presents the daily intakes (DIs) estimated for DBP, BBP,
DIBP, DEHP and DINP from 1988 to 2015. The period between 1988
and 1993 generally saw the highest exposures, with DBP and DEHP
contributing most to the DIs. From then on, their DIs steadily declined.
By 2015, the exposure patterns had changed markedly, with overall
declines for all phthalates except DINP. In 2015, DINP and DEHP, but
not DBP, were the most significant contributors. For each phthalate,
there were specific changes, as follows:
In 1988, DBP was by far the most prominent phthalate, with DIs that
in 1993 reached a peak of 42.3 µg/kg bw/day at the 95th percentile.
After 1993, exposures began to decline steadily to a value of 0.92 µg/kg
bw/day in 2015.
BBP had the highest DIs at the 95th percentile in the year 1996
(5.12 µg/kg bw/day) which fell to 0.63 µg/kg bw/day in 2015.
Similar to DBP, the DI of DEHP at the 95th percentile was highest
between 1991 and 1996, with a maximum of 22.2 µg/kg bw/day in the
year 1991. After 1996, it decreased to 3.07 µg/kg bw/day in 2015 (95th
percentile).
The DI of DIBP increased until 1991, then entered a slow decline
until it peaked at the 95th percentile in the years 2006 and 2008, with
9.23 and 8.78 µg/kg bw/day, respectively. Since then, exposures
dropped to 1.64 µg/kg bw/day in 2015.
The DI of DINP at the 95th percentile was highest in 1998 (11.2 µg/
kg bw/day) and then dropped to 3.7 µg/kg bw/day in 2015. Similar
declining trends became apparent for the median DIs of all phthalates,
except for DINP which showed an increasing tendency.
3.2. Hazard Index (HI) and Maximum Cumulative Ratio (MCR)
Table 5 presents the Hazard Indices, Risk Quotients and Maximum
Cumulative Ratios for the years 1988 to 2015. The decreasing phthalate
exposures led to declining HIs. After an initial rise from 1988 until
1993, the HIs dropped, both at the 95th percentile and as geometric
means (Fig. 2a). This development can be attributed to the falling RQs
for DBP and DEHP over time. By contrast, the RQs for the other
phthalates fluctuated or even increased slightly (DINP) between 1988
and 2015 (Fig. 2b). As a result, the more recent HIs were driven by a
greater number of phthalates, reflected in the slight upwards gradient
of the regression lines of MCR versus study year (Fig. 2a).
Scatter plots of MCRp versus HIp for each year are presented in the
Supplementary Material. They show clouds of data points which pro-
gressively shift leftwards towards lower HIs and upwards towards
higher MCRs as the years advance. Here we focus on three years which
mark key stages of the trajectory of changing phthalate exposures
Table 3
Parameters for the estimation of daily intakes (DI) from urinary phthalate metabolites.
Phthalate Molecular weight [g/
mol]




Sum of molar excretion factors, if more than one
metabolite is considered
DBP 278.34 MBP 222.24 0.691 (24 h)*1
DIBP 278.34 MIBP 222.24 0.707 (48 h)*2
BBP 312.36 MBzP 256.25 0.73 (24 h)*1
DEHP 390.56 MEHP 278.34 0.063 (48 h)*3 All 4 metabolites: 0.471
5OH-MEHP 294.34 0.156 (48 h)*3
5oxo-MEHP 292.33 0.113 (48 h)*3
5cx-MEPP 308.33 0.139 (48 h)*3
DINP 418.61 cx-MINP 322.35 0.109 (48 h)*3 All 3 metabolites: 0.298
OH-MINP 308.37 0.123 (48 h)*3
oxo-MINP 306.36 0.066 (48 h)*3
MBP: mono-n-butyl phthalate, MIBP: mono-iso-butyl phthalate, MBzP: mono benzyl phthalate, MEHP: mono(2-ethylhexyl) phthalate, 5OH-MEHP: mono(2-ethyl-5-
hydroxy-hexyl) phthalate, 5oxo-MEHP: mono(2-ethyl-5-oxo-hexyl) phthalate, 5cx-MEPP: mono(2-ethyl-5-carboxy-pentyl) phthalate, cx-MINP: 7-Carboxy-(mono-
methyl-heptyl) phthalate; OH-MINP: 7-OH–(Mono-methyl-octyl) phthalate, oxo-MINP: 7-Oxo-(Mono-methyl-octyl) phthalate, *1: Anderson et al., 2001, *2: Koch
et al., 2012, *3: Anderson et al., 2011
Table 4
Daily Intakes [µg/kg bw/day] for 5 phthalates described with sample size n, range, median (P50 = 50th percentile) and P95 (95th percentile) for the years
1988–2015.
Year n DBP BBP DIBP DEHP DINP
Range P50 P95 Range P50 P95 Range P50 P95 Range P50 P95 Range P50 P95
1988 60 0.72–27.8 6.97 22.9 0.01–6.58 0.25 0.76 0.26–6.02 1.09 3.44 0.99–52.1 4.89 12.1 0.09–3.29 0.30 1.93
1989 60 1.48–70.1 7.54 21.3 0.07–2.82 0.30 1.77 0.30–12.6 0.98 3.78 1.07–42.2 5.19 11.9 0.04–19.8 0.35 2.97
1991 60 2.13–28.7 6.42 14.2 0.11–2.84 0.43 1.54 0.35–19.7 1.21 8.31 1.46–29.8 5.08 22.2 0.07–30.9 0.33 5.62
1993 60 1.45–56.3 6.61 42.3 0.07–2.19 0.27 1.63 0.38–4.70 1.14 2.68 1.58–18.0 5.49 17.0 0.11–3.96 0.42 2.53
1996 145 1.05–90.2 3.68 15.1 0.04–27.3 0.29 5.12 0.43–28.3 1.54 7.90 0.91–38.3 4.53 16.9 0.09–5.24 0.51 2.46
1998 68 0.22–20.3 3.15 11.2 0.01–4.03 0.22 1.14 0.10–11.9 1.40 5.60 0.23–12.1 3.87 9.71 0.07–17.9 0.46 11.2
1999 60 0.83–32.8 2.77 15.5 0.03–10.9 0.21 3.49 0.40–14.7 1.46 4.12 1.29–18.5 3.46 10.7 0.05–4.81 0.50 2.65
2001 60 0.81–116 2.53 15.7 0.02–0.99 0.22 0.75 0.28–12.2 1.61 4.38 1.33–27.0 3.90 9.25 0.14–6.81 0.52 3.11
2002 57 0.71–121 2.47 5.69 0.08–2.31 0.27 1.38 0.43–4.42 1.23 3.58 1.67–22.1 3.63 7.29 0.03–11.9 0.94 2.37
2003 59 0.49–71.8 1.87 5.08 0.05–1.74 0.22 0.86 0.44–5.11 1.34 3.59 0.96–9.36 2.93 7.25 0.13–4.90 0.61 2.21
2004 58 0.50–56.2 1.54 4.51 0.07–6.51 0.24 0.74 0.37–3.43 1.04 2.58 1.28–17.8 3.52 13.7 0.17–9.59 0.84 3.00
2006 57 0.31–4.99 1.31 3.30 0.08–0.76 0.16 0.53 0.45–14.6 1.24 9.23 1.22–7.45 3.00 7.01 0.11–7.52 1.08 7.15
2007 60 0.13–2.52 0.74 1.61 0.02–1.90 0.14 0.79 0.21–10.1 0.93 3.62 0.47–47.6 2.44 12.0 0.08–6.89 0.55 4.57
2008 54 0.45–4.81 1.03 2.52 0.01–0.65 0.18 0.55 0.52–14.0 1.27 8.78 0.72–7.16 2.43 5.18 0.16–12. 1.24 6.01
2009 60 0.09–1.88 0.88 1.76 0.02–1.36 0.15 0.84 0.30–3.88 0.99 2.77 0.55–21.1 2.06 7.94 0.07–13.7 0.69 3.59
2011 60 0.21–1.83 0.64 1.29 0.02–2.29 0.13 0.55 0.37–6.59 0.88 2.00 0.50–4.47 1.54 3.16 0.19–34.9 0.72 4.47
2013 60 0.11–2.67 0.53 1.01 0.02–0.82 0.09 0.47 0.14–3.29 0.74 1.75 0.13–4.64 1.29 2.99 0.04–9.86 0.74 2.09
2015 60 0.07–0.97 0.43 0.92 0.01–5.15 0.05 0.63 0.11–33.0 0.47 1.64 0.35–15.6 0.95 3.07 0.23–10.1 0.57 3.70
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(Fig. 3): The pollution peak in 1993, compliance with acceptable levels
for single phthalates but exceedance of combined exposures with
HI > 1 (2006), and finally general compliance with HI = 1 (2011).
In 1993, most of the study population exceeded acceptable com-
bined exposures; some participants even reached HIs close to 10.
Furthermore, the exposures of over half of the participants also did not
comply with the acceptable levels for at least one phthalate, as is ap-
parent from the cloud of data points to the right of the line depicting
MCR = HI. Exposures in excess of acceptable levels for DBP, and to a
lesser degree to DEHP, were drivers of this situation. Strikingly
however, no participant showed MCRs larger than 2. For all study
subjects, at least 50% of the HI were attributable to only 1 phthalate, in
most cases DBP. Thus, in 1993, risks from phthalates could have been
significantly reduced by diminishing exposures to DBP. As shown in the
Supplementary Material, the years between 1993 and 1999 showed
similar characteristics.
The period after 1999 is characterised by a shift towards lower HIs
and higher MCRs, until in 2006 no study participant experienced ex-
posures that exceeded acceptable levels for a single phthalate (indicated
by the absence of data points to the right of the MCR = HI line, Fig. 3).
Table 5
Hazard Indices, Maximum Cumulative Ratios (MCR) and Risk Quotients for single phthalates for the years 1988 to 2015.
Year n % female Hazard Index MCR Risk quotient for single phthalate
DEHP DBP DIBP BBP DINP
GM* P95 GM P95 GM P95 GM P95 GM P95 GM P95 GM P95
1988 60 50 1.71 4.39 1.52 1.94 0.52 1.19 1.04 3.02 0.01 0.03 0.03 0.08 0.01 0.03
1989 60 50 1.76 4.27 1.56 2.02 0.52 1.15 1.10 3.06 0.01 0.03 0.03 0.09 0.01 0.04
1991 60 50 1.67 3.67 1.65 2.05 0.56 1.90 0.95 2.09 0.01 0.08 0.04 0.15 0.01 0.05
1993 60 50 1.84 7.50 1.56 1.98 0.57 1.60 1.11 5.71 0.01 0.03 0.03 0.10 0.01 0.04
1996 145 47 1.32 4.59 1.75 2.14 0.54 1.69 0.62 2.14 0.02 0.08 0.04 0.42 0.01 0.04
1998 68 44 0.98 2.37 1.75 2.15 0.38 1.00 0.49 1.56 0.02 0.06 0.03 0.08 0.01 0.16
1999 60 50 0.94 3.11 1.75 2.16 0.36 0.99 0.47 2.10 0.02 0.04 0.03 0.30 0.01 0.04
2001 60 50 0.99 3.11 1.72 2.14 0.39 0.86 0.46 1.25 0.02 0.04 0.02 0.07 0.01 0.04
2002 57 47 0.89 1.63 1.81 2.17 0.37 0.75 0.39 0.83 0.01 0.04 0.03 0.10 0.02 0.04
2003 59 49 0.69 1.29 1.79 2.17 0.31 0.71 0.29 0.68 0.01 0.03 0.02 0.08 0.01 0.04
2004 58 48 0.70 1.93 1.73 2.12 0.36 1.20 0.25 0.56 0.01 0.03 0.02 0.06 0.02 0.05
2006 57 49 0.57 1.12 1.85 2.31 0.28 0.63 0.21 0.48 0.02 0.05 0.02 0.05 0.02 0.11
2007 60 50 0.44 1.29 1.60 2.33 0.27 1.20 0.10 0.23 0.01 0.03 0.01 0.06 0.01 0.07
2008 54 46 0.48 0.82 1.80 2.25 0.24 0.52 0.15 0.38 0.01 0.04 0.02 0.05 0.02 0.10
2009 60 50 0.39 1.00 1.78 2.28 0.21 0.60 0.12 0.25 0.01 0.03 0.02 0.08 0.02 0.05
2011 60 50 0.30 0.62 1.87 2.27 0.15 0.29 0.09 0.17 0.01 0.02 0.01 0.05 0.02 0.07
2013 60 50 0.25 0.54 1.87 2.26 0.13 0.29 0.08 0.15 0.01 0.02 0.01 0.04 0.01 0.04
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Fig. 2a. Temporal trends for Hazard Index and Maximum Cumulative Ratio 1988–2015.Trends for HI and MCR, with box plots showing the geometric mean and the
95th percentile.
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However, in 2006, 7% of all subjects still exceeded combined exposures
of HI = 1. In continuation of the developments that set in after 1993, a
significant number of data points appeared above the MCR = 2 line.
For these participants combined risks are no longer due to only one
phthalate as the main contributor to the HI. Of particular concern are
those subjects in 2006 who fall above the MCR = 2 line, to the right of
the vertical HI = 1 line and to the left of the curved line MCR = HI.
These individuals experienced unacceptable combined exposures that
would have gone unnoticed in traditional single phthalate risk assess-
ment. At the same time, they could also not have been protected by
controlling exposure to one single phthalate.
By 2011, the lower exposures to DBP and DEHP that produced the
shift towards smaller HIs and larger MCRs after 1993 culminated in a
situation where most subjects stayed below combined acceptable
phthalate exposures; only one individual exceeded HI = 1. The re-














































Fig. 2b. Temporal trends for single phthalate Risk Quotients 1988-2015.
Trends for single DEHP, DBP, DIBP, BBP, and DINP Risk Quotients, with box









































Fig. 3. Analysis of combined phthalate exposures with MCR versus HI scatter
plots for 1993, 2006 and 2011. The results for individual study participants are
shown as blue dots. The vertical red line shows HI = 1, the horizontal red line is
for MCR = 2. The curved red line depicts MCR = HI. The red box in each plot
shows the range of HI between 0.1 and 0.2 as suggested values for evaluation of
combined phthalate exposures that can accommodate substances also con-
tributing to male reproductive risks.
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proportion of subjects experienced increasingly diverse phthalate ex-
posures, as indicated by the large number of data points above the
MCR = 2 line, with some reaching MCRs between 2.4 and 2.6. These
trends continued in 2015, with the largest MCR around 3, reflecting an
increased diversity of the combined exposures.
To further analyse the degree by which single phthalates have
driven cumulative exposures during the years between 1988 and 2015,
we investigated correlations between MCR and HI by preparing plots of
log (MCR – 1) versus log HI (Reyes and Price, 2018). During the pol-
lution peak in 1993, increasing HIp were associated with decreasing
MCRp (Fig. 4). This correlation disappeared in 2006 and 2011. How-
ever, as depicted in the graphs in the Supplementary Material, these
study years were an exception. In almost all other years there was an
inverse relationship between MCR and HI, demonstrating that subjects
with high combined exposures tended to experience relatively large
exposures to a smaller number of phthalates. Conversely, study parti-
cipants with relatively low combined phthalate exposures showed more
complex exposure patterns.
4. Discussion
4.1. Changes in the regulatory landscape as a contributory factor to
changing exposure patterns
Our analysis shows that declines in phthalate exposures in the
German Environmental Specimen Bank study population became no-
ticeable already at the end of the 1980s, with corresponding decreases
in the HIs. The continuation of the initial declines was supplanted by a
curious pollution peak around 1993, but after this episode HIs dimin-
ished year on year, which might be firstly attributable to the rating of
some phthalates as priority substances according to Council Regulation
(EEC) No 793/93 of 23 March 1993 on the evaluation and control of the
risks of existing substances. A further reason for an altered production
and usage of specific phthalates might be the Commission Decision
1999/815/EC of December 1999 on adopting measures prohibiting the
placing on the market of toys and childcare articles intended to be
placed in the mouth by children under three years of age and made of
soft PVC containing one or more of the substances DEHP, DBP, BBP,
DINP, DIDP, and DOP. Although this decision was restricted to special
toys only and was initially temporary, it can be assumed that there was
increasing awareness of risks associated with the use of the respective
phthalates. After multiple renewals the more general Directive 2005/
84/EC came into force. From 2006 onwards, the Directive restricts the
use of DEHP, DBP, and BBP in all toys and childcare articles with a
concentration limit of 0.1% by weight (entry 51 of Annex XVII to
REACH). DINP, DIDP, and DOP have only been restricted in toys that
can be taken into the mouth (0.1% mass percent of the plasticised part
of the toy, entry 52 of Annex XVII to REACH). Additionally,
Commission Directive 2004/93/EC led to a ban on DEHP and DBP in
cosmetics from 2005 onwards. In 2011 then, restrictions followed in
food contact materials (Commission Regulation (EU) No 10/2011 of 14
January 2011).
Due to the classification as reproductive toxicants, category 1B,
under Annex VI to the Classification, Labelling and Packaging of sub-
stances and mixtures (CLP) regulation ((EC) No 1272/2008 and
amendments) DEHP, DBP, DIBP, and BBP are substances of very high
concern and were added via the Candidate List of Substances for Au-
thorisation under REACH (in 2008/2009) to the Authorisation List
(Annex XIV) in 2012. This means that from February 2015 they are not
allowed to be produced in the EU unless authorisation has been granted
for a specific use, however they still may be imported in consumer
products. Further efforts for restriction of DEHP, DBP, DIBP, and BBP in
products have already been initiated (COMMISSION REGULATION
(EU) 2018/2005 of 17 December 2018 amending Annex XVII to
Regulation (EC) No 1907/2006).
Considering that the main route of exposure to medium- and long
chain phthalates is via food (Koch et al., 2013; Correia-Sá et al., 2018;
Giovanoulis et al., 2018; Husøy et al., 2019), lifestyle changes could
also have played a role. But these are possibly of minor importance, as
the prevalence of phthalates in food items is not immediately obvious to
the consumer, making rational choices for individual avoidance beha-
viour difficult. It seems that political pressure and the anticipation of
regulatory action has played a dominant role in substitution decisions
by industry, but only where it was possible to replace the more toxic
DBP and DEHP with alternative phthalates or non-ortho-phthalate
substitutes. The increasing trends in DINP exposures seen here and in
DINCH and DEHTP exposures observed by us and others
(Gyllenhammer et al., 2017; Silva et al., 2017; Kasper-Sonnenberg
et al., 2019; Lessmann et al., 2019) strongly point in this direction.
Although the use of different RfDs in constructing RQs complicates
direct comparisons with our values, similar trends were seen in the USA
(Reyes and Price, 2018; Zota et al., 2014). This suggests that the
changes we observed took place beyond the EU and are relevant in-
ternationally.
Fig. 4. Plots of log (MCRp – 1) versus log HIp for 1993, 2006 and 2011. Results
for individual study participants are represented by dots, together with the best
fitting linear regression line.
P. Apel, et al. Environment International 137 (2020) 105467
9
4.2. Changing exposure patterns and Maximum Cumulative Ratio
The rather high HIs experienced by study subjects in the earlier
years of our time series study could have been lessened by reducing
exposures to a single phthalate, DBP. The rather low MCR values,
especially among subjects with high HIs to the right of the MCR = HI
line in Fig. 3, indicate that the main issue was exceedance of acceptable
exposures to a single phthalate (DBP and, to a lesser degree, DEHP). But
even with MCR values as low as 1.2 to 1.4, the combined exposures
missed by neglecting to conduct a mixture risk assessment are between
17 and 30%.
The high exposures that characterised the decade from 1988 to
about 1999 fuel concerns about adverse health effects in males born
during this time. Only from 2011 onwards was a situation reached
where most individuals did not experience phthalate exposures in ex-
cess of HI = 1. It will be timely to confirm or refute these concerns in
epidemiological studies.
The declining DIs of DBP and DEHP led to a development char-
acterised by an increasing complexity of combined phthalate exposures.
The consequence are lower HIs but with correspondingly increasing
MCRs. This becomes obvious from a leftward and upward shift of the
data clouds in MCR versus HI plots as the years advance (Fig. 3 and
Supplementary Material). As shown by the inverse relationship between
MCR and HI, the high combined phthalate exposures experienced by
some study participants tended to be attributable to a relatively small
number of phthalates. Most of the gradients in the log (MCR – 1) versus
log HI plots (−0.2 to −0.6) were similar to those reported for NHANES
data (Reyes and Price 2018). It would seem that the emerging exposure
patterns will become more and more difficult to manage as any attempt
to reduce risks further cannot be achieved other than by targeting
multiple phthalates.
4.3. Exposures to other anti-androgens, beyond phthalates
With a focus on 5 phthalates, our analysis is limited as it can only
capture a fraction of the potential risks to male reproductive health.
First, there are other phthalates, such as DIDP or the linear or branched
side chain pentyl and hexyl phthalates that could also contribute to
risks. Furthermore, experimental evidence shows that phthalates pro-
duce combination effects with a wide variety of other substances also
capable of interfering with hormone action (reviewed by Kortenkamp,
2020; Howdeshell et al., 2017). These include androgen receptor an-
tagonists (certain dicarboximide pesticides, parabens, bisphenol A),
chemicals that inhibit steroidogenic and steroid-converting enzymes
(certain imidazole and phenylurea pesticides, and the drug finasteride),
substances interfering with the transport of androgen precursors (lipid-
lowering drugs), and those capable of disrupting prostaglandin signal-
ling by inhibition of Cox enzymes (certain analgesics including para-
cetamol and a wide variety of phenolic substances). Polychlorinated
dioxins and biphenyls also contribute to risks via poorly defined path-
ways. Thus, common adverse outcomes overlapping with the effect
spectrum of the phthalate syndrome can be induced through multiple
interacting and converging pathways that involve numerous chemicals
with diverse structural features. Human exposure to many of these
substances is as widespread and common as to phthalates (Kortenkamp,
2020).
4.4. Risk assessment options for dealing with co-exposures to other anti-
androgens
This evidence calls for caution in applying a HI = 1 as the bench-
mark for evaluating the outcome of phthalate mixture risk assessments.
HI = 1 leaves no room for co-exposures to other substances that also
disrupt the normal development of the male reproductive system.
Evaluating combined phthalate exposures against HI = 1 tacitly as-
sumes that phthalates are emitted into a pristine environment with no
background exposure to other chemicals that also contribute to dis-
ruptions of male reproductive health. This is clearly not the case.
There are two options for dealing with this situation. First, a more
comprehensive mixture risk assessment that includes the substances
also contributing to combined exposures could be conducted. However,
this requires the assembly of adequate exposure data and the derivation
of reference doses for use in the HI approach, a task well beyond the
scope of this paper, but which is tackled within the framework of the
European Initiative HBM4EU under work package 15 (https://www.
hbm4eu.eu/).
Alternatively, combined phthalate exposures could be evaluated
against a lowered HI, in recognition of the fact that the “risk cup“ for
male reproductive disorders is not solely made up by phthalates. The
question is what should be regarded as an acceptable HI and to what
degree the HI = 1 should be lowered.
An answer to this question requires knowledge of the number of
chemicals, apart from phthalates, that also contribute to male re-
productive risks, together with the relative contribution of each cor-
responding RQ to the HI. However, this information is currently not
available. Thus, the choice of an acceptable HI below 1 is at present
arbitrary. Even so, informed guesses can be made. Considering that in
addition to the group of phthalates as a whole at least 10 further sub-
stances are likely to contribute to the combined exposures
(Kortenkamp, 2020), it is not unrealistic to assume that phthalates
alone make up 10% of the exposure of the entire risk cup. Accordingly,
the group of phthalates alone would have to be evaluated using a
lowered HI of 0.1. If however some of the non-phthalates with anti-
androgenic properties make a disproportionately large contribution to
the HI, while others add little, the phthalate share of the risk cup could
increase to perhaps 20%. In this case, the HI of phthalates alone would
have to be evaluated against a less stringent value of 0.2.
We emphasise that these considerations are speculative, but not
implausible. They are equivalent to proposals of Mixture Assessment
Factors of 10 by the Swedish KEMI (2015) and the Dutch RIVM (van
Broekhuizen et al., 2016) and agree with very recent recommendations
of a Swedish Government enquiry into how to improve the group-wise
management of hazardous chemicals (Swedish Government Enquiries
2019). We therefore recommend 0.1 to 0.2 for the assessment of
phthalate exposures until more information about exposures to other
anti-androgens becomes available that allows upwards revisions of this
value.
Evaluated against these lowered HIs of 0.1–0.2, the combined
phthalate exposures of most study participants exceed levels that can be
regarded as acceptable. This gives reason to continue monitoring po-
tential exceedances of health-based guidance values in order to provide
the basis for appropriate risk management measures.
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